Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — Tasca Therapeutics Corp

0002046762-25-000005 · filed Dec 1, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$70,199,981
Reported amount sold
$48,099,985
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Tasca Therapeutics Corp
CIK
2046762
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2021
Address
55 SPINELLI PLACE
CAMBRIDGE, Massachusetts 02138
Phone
617-390-4306

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗